TerrAscend (OTCMKTS:TSNDF) Trading Up 16.1% - Should You Buy?

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report)'s share price traded up 16.1% on Tuesday . The company traded as high as $0.65 and last traded at $0.65. 484,959 shares were traded during mid-day trading, an increase of 54% from the average session volume of 314,862 shares. The stock had previously closed at $0.56.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets lowered TerrAscend from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 9th.

TerrAscend Stock Performance

The company has a quick ratio of 0.69, a current ratio of 1.35 and a debt-to-equity ratio of 0.81. The firm has a fifty day simple moving average of $0.63 and a two-hundred day simple moving average of $0.99.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.04). The firm had revenue of $74.17 million for the quarter, compared to the consensus estimate of $77.15 million. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. As a group, research analysts expect that TerrAscend Corp. will post -0.14 earnings per share for the current fiscal year.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.